Vertex stock jumps 4% as earnings date nears — what traders watch next for VRTX
New York, Jan 22, 2026, 05:11 EST — Premarket Vertex Pharmaceuticals (VRTX) shares jumped 4.31%, closing Wednesday at $461.14 and marking their third straight session of gains. Trading volume climbed past the stock’s 50-day average. VRTX outperformed peers like AbbVie, Krystal Biotech, and Arcturus Therapeutics, while the S&P 500 and Dow each gained over 1%. (MarketWatch) Vertex is now under…